CEACAM5 and neoplasm: One potential tumor-specific target is carcinoembryonic antigen (CEA), as 74.5–90% of gastric cancers have been shown to express CEA by immunohistochemistry.26,27 We have previously utilized the poorly differentiated gastric adenocarcinoma cell line, MKN45, to create orthotopic mouse models of gastric cancer.